Research findings to Therapeutic opportunity:
The study presented here suggests that MiRNA-9600, by increasing the expression of its target genes, it may decrease the expression of protein that is enriched in cancer stem cells, such as Nanog.
Thereby, it may inhibit proliferation, and promote apoptosis of cancer cells. Thus, pharmacological formulations encompassing “MiRNA-9600 activators” may be used to inhibit cancer progression.
Details of the research findings:
Idea Proposed/Formulated (with experimental evidence) by:
Dr L Boominathan Ph.D.
Undisclosed mechanistic information: How does MiRNA-9600 decrease the expression of Nanog ?
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
For purchase and payment details, you may reach us at firstname.lastname@example.org
Citation: Boominathan, L., Anticancer therapy targeting the cancer stem cells: MiRNA-9600 inhibits the expression of stem cell gene/reprogramming protein Nanog, suppresses proliferation, and promotes apoptosis of cancer cells via down regulation of its target gene, 24/January/2016, 10.53 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com